Industry: Pharmaceuticals, Biotechnology
ALDAGEN, Inc. is creating a significant franchise in tissue repair and regeneration, with initial focus on the treatment of cardiovascular disease and peripheral artery disease. The Company´s proprietary product, ALDESORT, provides identification, isolation and therapeutic administration of a unique population of adult stem cells. These therapeutic cell populations have shown impressive potential to replace lost, damaged or diseased tissues in animal models and are now being tested in human clinical trials. To support ALDESORT´s clinical development, the Company has established efficient and effective quality, manufacturing, and regulatory operations that satisfy FDA ( www.aldagen.com )
ALDAGEN Inc
810 Meridian Parkway Suite 148
Durham, North Carolina 27713
USA
Tel: (919) 484-2571